Article Text
Law, ethics and medicine
Paper
The best argument against kidney sales fails
Abstract
Simon Rippon has recently argued against kidney markets on the grounds that introducing the option to vend will result in many people, especially the poor, being subject to harmful pressure to vend. Though compelling, Rippon's argument fails. What he takes to be a single phenomenon—social and legal pressure to vend—is actually two. Only one of these forms of pressure is, by Rippon's own account, harmful. Further, an empirically informed view of the regulated market suggests that this harmful pressure is easily avoided. Thus, the harm that is the lynchpin of Rippon's opposition is neither a necessary feature of the market nor is it likely to play a significant role in its operation.
- Kidneys
- Public Policy
- Regulation
- Transplantation
- Applied and Professional Ethics
Statistics from Altmetric.com
Linked Articles
- The concise argument
Other content recommended for you
- Choice, pressure and markets in kidneys
- Imposing options on people in poverty: the harm of a live donor organ market
- The ethics of biomedical markets
- Black markets, transplant kidneys and interpersonal coercion
- Understanding choice, pressure and markets in kidneys
- A legal market in organs: the problem of exploitation
- Organ markets and harms: a reply to Dworkin, Radcliffe Richards and Walsh
- Human organs, scarcities, and sale: morality revisited
- Methods and principles in biomedical ethics
- Would you sell a kidney in a regulated kidney market? Results of an exploratory study